The research team tested the scanner in a pre-clinical study involving 10 patients with conditions such as type-2 diabetes, rheumatoid arthritis, and breast cancer, along with seven healthy volunteers. In patients with diabetes, the scanner generated detailed images of microvasculature in the feet, highlighting changes in blood vessel structure, a potential early indicator of tissue damage.
This is particularly significant for conditions like peripheral vascular disease (PVD), a common complication of diabetes, where early changes in blood vessels often go undetected by conventional imaging methods.
The scanner also holds promise for cancer diagnosis. The photoacoustic imaging could help detect tumors and assist surgeons in distinguishing cancerous tissue from healthy tissue. The scanner’s sensitivity to hemoglobin, a light-absorbing molecule, allows it to capture detailed images of blood vessels that conventional imaging tools might miss.